MSCL
$0.63
-3.077%

Satellos Bioscience Inc.
Insider Activity

Last updated: Apr 9, 2025, 3:27 AM ET

Profile

Company Description

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Sector

Healthcare

Industry

Biotechnology

Insider Activity

Financial Data provided by QuoteMedia captures transactions reported on SEDI. To view this company’s financial statements, please visit the Financials & Filings.

Time Range
3 Months
BUYING/SELLING BY INSIDER
Buys
3
months
2 Buys
# of Shares 81,444
Sells
3
months
0 Sells
# of Shares 0